Klotho Sensitivity of the Neuronal Excitatory Amino Acid Transporters EAAT3 and EAAT4

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Almilaji, Ahmad ^a   Munoz, Carlos ^a   Pakladok, Tatsiana ^a   Alesutan, Ioana ^a   Feger, Martina ^a   Föller, Michael ^a   Lang, Undine E ^b   Shumilina, Ekaterina ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 3; EXCITATORY AMINO ACID TRANSPORTER 4; GLUTAMIC ACID; KLOTHO PROTEIN; RECOMBINANT PROTEIN; RNA; SACCHAROLACTONE;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CHEMOLUMINESCENCE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; NONHUMAN; OOCYTE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; VOLTAGE CLAMP; XENOPUS;

ACTION POTENTIALS; ANIMALS; BIOLOGICAL TRANSPORT; EXCITATORY AMINO ACID TRANSPORTER 3; EXCITATORY AMINO ACID TRANSPORTER 4; GENE EXPRESSION; GLUCURONIDASE; GLUTAMIC ACID; NEURONS; OOCYTES; XENOPUS LAEVIS;

EID: 84880769827     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070988     Document Type: Article

References (75)

1. Takeshita K, Fujimori T, Kurotaki Y, Honjo H, Tsujikawa H, et al. (2004) Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression. Circulation 109: 1776-1782.
2. Tsujikawa H, Kurotaki Y, Fujimori T, Fukuda K, Nabeshima Y, (2003) Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 17: 2393-2403.
3. Imura A, Iwano A, Tohyama O, Tsuji Y, Nozaki K, et al. (2004) Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett 565: 143-147.
4. Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, et al. (2010) Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 24: 3438-3450.
5. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, et al. (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51.
6. Kuro-o M, (2010) Klotho. Pflugers Arch 459: 333-343.
7. Razzaque MS, Sitara D, Taguchi T, St Arnaud R, Lanske B, (2006) Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 20: 720-722.
8. Yoshida T, Fujimori T, Nabeshima Y, (2002) Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene. Endocrinology 143: 683-689.
9. Ramasamy I, (2006) Recent advances in physiological calcium homeostasis. ClinChemLab Med 44: 237-273.
10. Segawa H, Yamanaka S, Ohno Y, Onitsuka A, Shiozawa K, et al. (2007) Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice. Am J Physiol Renal Physiol 292: F769-F779.
11. Kuro-o M, (2006) Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. CurrOpinNephrolHypertens 15: 437-441.
12. Ohnishi M, Nakatani T, Lanske B, Razzaque MS, (2009) Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int 75: 1166-1172.
13. Voelkl J, Alesutan I, Leibrock CB, Quintanilla-Martinez L, Kuhn V, et al. (2013) Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest.
14. Dermaku-Sopjani M, Sopjani M, Saxena A, Shojaiefard M, Bogatikov E, et al. (2011) Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho. Cell Physiol Biochem 28: 251-258.
15. Sopjani M, Alesutan I, Dermaku-Sopjani M, Gu S, Zelenak C, et al. (2011) Regulation of the Na+/K+ ATPase by Klotho. FEBS Lett 585: 1759-1764.
16. Boros S, Bindels RJ, Hoenderop JG, (2009) Active Ca(2+) reabsorption in the connecting tubule. Pflugers Arch 458: 99-109.
17. Cha SK, Hu MC, Kurosu H, M K-o, Moe O, et al. (2009) Regulation of renal outer medullary potassium channel and renal K(+) excretion by Klotho. Mol Pharmacol 76: 38-46.
18. Bailey CG, Ryan RM, Thoeng AD, Ng C, King K, et al. (2011) Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria. J Clin Invest 121: 446-453.
19. Peghini P, Janzen J, Stoffel W, (1997) Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration. EMBO J 16: 3822-3832.
20. O'Kane RL, Martinez-Lopez I, DeJoseph MR, Vina JR, Hawkins RA, (1999) Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J BiolChem 274: 31891-31895.
21. Amara SG, Fontana AC, (2002) Excitatory amino acid transporters: keeping up with glutamate. NeurochemInt 41: 313-318.
22. Collin M, Backberg M, Ovesjo ML, Fisone G, Edwards RH, et al. (2003) Plasma membrane and vesicular glutamate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight. EurJ Neurosci 18: 1265-1278.
23. Furuta A, Rothstein JD, Martin LJ, (1997) Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J Neurosci 17: 8363-8375.
24. Furuta A, Takashima S, Yokoo H, Rothstein JD, Wada K, et al. (2005) Expression of glutamate transporter subtypes during normal human corticogenesis and type II lissencephaly. Brain ResDevBrain Res 155: 155-164.
25. Huang YH, Dykes-Hoberg M, Tanaka K, Rothstein JD, Bergles DE, (2004) Climbing fiber activation of EAAT4 transporters and kainate receptors in cerebellar Purkinje cells. J Neurosci 24: 103-111.
26. Nieoullon A, Canolle B, Masmejean F, Guillet B, Pisano P, et al. (2006) The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse? J Neurochem 98: 1007-1018.
27. Shashidharan P, Huntley GW, Murray JM, Buku A, Moran T, et al. (1997) Immunohistochemical localization of the neuron-specific glutamate transporter EAAC1 (EAAT3) in rat brain and spinal cord revealed by a novel monoclonal antibody. Brain Res 773: 139-148.
28. Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH, (2001) Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. AmJ Psychiatry 158: 1393-1399.
29. Schniepp R, Kohler K, Ladewig T, Guenther E, Henke G, et al. (2004) Retinal colocalization and in vitro interaction of the glutamate transporter EAAT3 and the serum- and glucocorticoid-inducible kinase SGK1 [correction]. Invest OphthalmolVisSci 45: 1442-1449.
30. Maragakis NJ, Dietrich J, Wong V, Xue H, Mayer-Proschel M, et al. (2004) Glutamate transporter expression and function in human glial progenitors. Glia 45: 133-143.
31. Miralles VJ, Martinez-Lopez I, Zaragoza R, Borras E, Garcia C, et al. (2001) Na+ dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) in primary astrocyte cultures: effect of oxidative stress. Brain Res 922: 21-29.
32. Schmitt A, Zink M, Petroianu G, May B, Braus DF, et al. (2003) Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain. NeurosciLett 347: 81-84.
33. van Landeghem FK, Weiss T, von Deimling A, (2007) Expression of PACAP and glutamate transporter proteins in satellite oligodendrocytes of the human CNS. RegulPept 142: 52-59.
34. Huang YH, Sinha SR, Tanaka K, Rothstein JD, Bergles DE, (2004) Astrocyte glutamate transporters regulate metabotropic glutamate receptor-mediated excitation of hippocampal interneurons. J Neurosci 24: 4551-4559.
35. Grewer C, Gameiro A, Zhang Z, Tao Z, Braams S, et al. (2008) Glutamate forward and reverse transport: from molecular mechanism to transporter-mediated release after ischemia. IUBMBLife 60: 609-619.
36. Deng X, Shibata H, Takeuchi N, Rachi S, Sakai M, et al. (2007) Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia. AmJ MedGenetB NeuropsychiatrGenet 144B: 271-278.
37. Huerta I, McCullumsmith RE, Haroutunian V, Gimenez-Amaya JM, Meador-Woodruff JH, (2006) Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia. Synapse 59: 394-402.
38. Kim JH, Do SH, Kim YL, Zuo Z, (2005) Effects of chronic exposure to ethanol on glutamate transporter EAAT3 expressed in Xenopus oocytes: evidence for protein kinase C involvement. Alcohol Clin ExpRes 29: 2046-2052.
39. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J, (2007) Molecular mechanisms of schizophrenia. Cell Physiol Biochem 20: 687-702.
40. McCullumsmith RE, Meador-Woodruff JH, (2002) Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 26: 368-375.
41. Nudmamud-Thanoi S, Piyabhan P, Harte MK, Cahir M, Reynolds GP (2007) Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia. J Neural TransmSuppl: 281-285.
42. Crino PB, Jin H, Shumate MD, Robinson MB, Coulter DA, et al. (2002) Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia 43: 211-218.
43. Mathern GW, Mendoza D, Lozada A, Pretorius JK, Dehnes Y, et al. (1999) Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 52: 453-472.
44. Proper EA, Hoogland G, Kappen SM, Jansen GH, Rensen MG, et al. (2002) Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 125: 32-43.
45. Rakhade SN, Loeb JA, (2008) Focal reduction of neuronal glutamate transporters in human neocortical epilepsy. Epilepsia 49: 226-236.
46. Simantov R, Crispino M, Hoe W, Broutman G, Tocco G, et al. (1999) Changes in expression of neuronal and glial glutamate transporters in rat hippocampus following kainate-induced seizure activity. Brain ResMolBrain Res 65: 112-123.
47. Chan H, Zwingmann C, Pannunzio M, Butterworth RF, (2003) Effects of ammonia on high affinity glutamate uptake and glutamate transporter EAAT3 expression in cultured rat cerebellar granule cells. NeurochemInt 43: 137-146.
48. Alesutan IS, Ureche ON, Laufer J, Klaus F, Zurn A, et al. (2010) Regulation of the glutamate transporter EAAT4 by PIKfyve. Cell Physiol Biochem 25: 187-194.
49. Klaus F, Laufer J, Czarkowski K, Strutz-Seebohm N, Seebohm G, et al. (2009) PIKfyve-dependent regulation of the Cl- channel ClC-2. Biochem BiophysResCommun 381: 407-411.
50. Rajamanickam J, Palmada M, Lang F, Boehmer C, (2007) EAAT4 phosphorylation at the SGK1 consensus site is required for transport modulation by the kinase. J Neurochem 102: 858-866.
51. Wang Y, Chen L, Huang G, He D, He J, et al. (2013) Klotho sensitizes human lung cancer cell line to cisplatin via PI3k/Akt pathway. PLoS One 8: e57391.
52. Dowd LA, Robinson MB, (1996) Rapid stimulation of EAAC1-mediated Na+-dependent L-glutamate transport activity in C6 glioma cells by phorbol ester. J Neurochem 67: 508-516.
53. Dowd LA, Coyle AJ, Rothstein JD, Pritchett DB, Robinson MB, (1996) Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1). MolPharmacol 49: 465-473.
54. Bohmer C, Philippin M, Rajamanickam J, Mack A, Broer S, et al. (2004) Stimulation of the EAAT4 glutamate transporter by SGK protein kinase isoforms and PKB. Biochem BiophysResCommun 324: 1242-1248.
55. Strutz-Seebohm N, Pusch M, Wolf S, Stoll R, Tapken D, et al. (2011) Structural basis of slow activation gating in the cardiac I Ks channel complex. Cell Physiol Biochem 27: 443-452.
56. Bogatikov E, Munoz C, Pakladok T, Alesutan I, Shojaiefard M, et al. (2012) Up-regulation of amino acid transporter SLC6A19 activity and surface protein abundance by PKB/Akt and PIKfyve. Cell Physiol Biochem 30: 1538-1546.
57. Alesutan I, Sopjani M, Dermaku-Sopjani M, Munoz C, Voelkl J, et al. (2012) Upregulation of Na-coupled glucose transporter SGLT1 by Tau tubulin kinase 2. Cell Physiol Biochem 30: 458-465.
58. Pathare G, Foller M, Daryadel A, Mutig K, Bogatikov E, et al. (2012) OSR1-Sensitive Renal Tubular Phosphate Reabsorption. Kidney Blood Press Res 36: 149-161.
59. Henrion U, Zumhagen S, Steinke K, Strutz-Seebohm N, Stallmeyer B, et al. (2012) Overlapping cardiac phenotype associated with a familial mutation in the voltage sensor of the KCNQ1 channel. Cell Physiol Biochem 29: 809-818.
60. Hosseinzadeh Z, Bhavsar SK, Lang F, (2012) Downregulation of ClC-2 by JAK2. Cell Physiol Biochem 29: 737-742.
61. Mia S, Munoz C, Pakladok T, Siraskar G, Voelkl J, et al. (2012) Downregulation of Kv1.5 K Channels by the AMP-Activated Protein Kinase. Cell Physiol Biochem 30: 1039-1050.
62. Imura A, Tsuji Y, Murata M, Maeda R, Kubota K, et al. (2007) alpha-Klotho as a regulator of calcium homeostasis. Science 316: 1615-1618.
63. Lang F, Rehwald W, (1992) Potassium channels in renal epithelial transport regulation. Physiol Rev 72: 1-32.
64. Hertz L, (2008) Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacology 55: 289-309.
65. Chen CD, Sloane JA, Li H, Aytan N, Giannaris EL, et al. (2013) The Antiaging Protein Klotho Enhances Oligodendrocyte Maturation and Myelination of the CNS. J Neurosci 33: 1927-1939.
66. Maddock RJ, Buonocore MH (2012) MR Spectroscopic Studies of the Brain in Psychiatric Disorders. CurrTopBehavNeurosci.
67. Kavalali ET, Monteggia LM, (2012) Synaptic mechanisms underlying rapid antidepressant action of ketamine. AmJ Psychiatry 169: 1150-1156.
68. Bauer D, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE, (2010) Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia. SchizophrRes 117: 92-98.
69. Rao JS, Kellom M, Reese EA, Rapoport SI, Kim HW, (2012) Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J AffectDisord 136: 63-71.
70. Shan D, Lucas EK, Drummond JB, Haroutunian V, Meador-Woodruff JH, et al. (2013) Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia. SchizophrRes 144: 1-8.
71. Gourley SL, Swanson AM, Jacobs AM, Howell JL, Mo M, et al. (2012) Action control is mediated by prefrontal BDNF and glucocorticoid receptor binding. ProcNatlAcadSciUSA 109: 20714-20719.
72. Sanacora G, Kendell SF, Levin Y, Simen AA, Fenton LR, et al. (2007) Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. BiolPsychiatry 61: 822-825.
73. Kosakai A, Ito D, Nihei Y, Yamashita S, Okada Y, et al. (2011) Degeneration of mesencephalic dopaminergic neurons in klotho mouse related to vitamin D exposure. Brain Res 1382: 109-117.
74. Abraham CR, Chen C, Cuny GD, Glicksman MA, Zeldich E, (2012) Small-molecule Klotho enhancers as novel treatment of neurodegeneration. FutureMedChem 4: 1671-1679.
75. Teocchi MA, Ferreira AE, da Luz de Oliveira EP, Tedeschi H, D'Souza-Li L, (2013) Hippocampal gene expression dysregulation of Klotho, nuclear factor kappa B and tumor necrosis factor in temporal lobe epilepsy patients. J Neuroinflammation 10: 53.